BSECompany Update21 Oct 2026 · 21 Oct 2026, 03:04 pm
Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter and Half year ended 30th September 2026
Indoco Remedies Ltd · 532612
✦ AI SummaryResults
Indoco Remedies Ltd has announced an earnings conference call for Q2 FY2026-2027, scheduled for October 27, 2026, to discuss unaudited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
3bb1a04e-51ac-4b69-a671-4c40d3b80e78.pdf
View document text
21st October, 2026
To To
The Listing Department The Listing Department
National Stock Exchange of India Limited Bombay Stock Exchange Limited
Exchange Plaza, Floor 25, P. J. Towers,
Bandra – Kurla Complex Dalal Street,
Bandra (East) Mumbai – 400 001
Mumbai – 400 051 Stock Code : 532612
Stock Code : INDOCO
Dear Sir/Madam,
Sub : Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter
and Half year ended 30th September, 2026
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings
Conference Call on Unaudited Financial Results for the Quarter and Half year ended 30th
September, 2026 is scheduled to be held on Tuesday, 27th October, 2026 at 03:00 P.M. IST.
The details of the conference call are enclosed herewith.
This is for your information and dissemination on respective websites.
Thanking you,
Yours faithfully,
For Indoco Remedies Limited
Ramanathan Hariharan
Company Secretary & Head Legal
You are cordially invited to the
Q2 FY2026-2027 Earnings Conference Call of
Indoco Remedies Limited
Tuesday, October 27, 2026 at 3:00PM IST
Represented by:
Ms. Aditi Panandikar Managing Director
Mr. Sundeep V. Bambolkar Jt. Managing Director
Mr. Pramod Ghorpade CFO
Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link
Conference Dial-In Number
+91 22 6280 1116
Universal Access
+91 22 7115 8017
Hong Kong: 800 964 448
Singapore: 800 101 2045
International Toll Free
USA: 1 866 746 2133
UK: 0 808 101 1573
For further information, please contact:
Rashmi Shetty Candice Pereira Zain Gulam Hussain
Director - Research AVP Research Associate
Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd.
(D) +91 22 40969724 (D) +91 22 61764873 (D) +91 22 40969790
(M) +91 22 8879111413 (M) +91 22 9833458572 (M) +91 22 9892724209
Email: rashmis@dolatcapital.com Email: candicep@dolatcapital.com Email: zain@dolatcapital.com